FDA calls for healthcare worker feedback to enhance monitoring of AI-enabled medical devices in real-world settings.
Key Details
- 1FDA opens comment window (Sept 30–Dec 1) for real-world monitoring of AI-equipped devices.
- 2Agency seeks input on detection and mitigation of data/model drift and performance changes.
- 3Most current evaluations rely on static retrospective testing, which FDA says is insufficient.
- 4End-users with experience of deployed AI tools are specifically invited to contribute insights.
- 5Recent breakthroughs: FDA Breakthrough Device status for Aidoc's AI triage solution; new AI approaches to body composition assessment (Mass General Brigham), and mammogram-based CVD risk prediction.
Why It Matters
Robust post-market monitoring and ongoing user feedback are vital as more AI tools are deployed in radiology and medical imaging. These regulatory efforts shape safe, effective, and continually improving AI integration in clinical practice.
Source
AI in Healthcare
Related News
•Radiology Business
Less than 30% of Radiology AI Devices Undergo Clinical Testing Before FDA Clearance
A new study finds that under 30% of radiology-focused AI/ML devices authorized by the FDA had clinical testing prior to authorization.
•Cardiovascular Business
AI Model Dramatically Enhances Severe Heart Attack Detection via ECGs
Queen of Hearts AI model outperforms standard care in detecting severe heart attacks from ECGs.
•Radiology Business
ACR Advises White House on Oversight for Radiology AI
The American College of Radiology (ACR) provided the White House with recommendations on regulating and monitoring AI technologies in clinical radiology.